AGTC

AGTC NASDAQ
3.880
-0.030
0.00%
Closed 16:00 07/19 EDT
Open
3.860
Prev Close
3.880
High
4.030
Low
3.860
Volume
196.08K
Avg Vol (3M)
47.97K
52 Week High
7.50
52 Week Low
2.260
% Turnover
1.08%
Market Cap
70.50M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers AGTC AGTC stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).
MORE >

Recently

Name
Price
%Change